Report Detail

Request for Sample of this report

Medical Devices & Consumables Global and United States Rheumatoid Arthritis Devices Market Report & Forecast 2022-2028

  • RnM4420656
    • |
  • 06 April, 2022
    • |
  • Global
    • |
  • 117 Pages
    • |
  • QYResearch
    • |
  • Medical Devices & Consumables

Summary:

Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease that primarily affects the lining of the synovial joints and is associated with progressive disability, premature death, and socioeconomic burdens.the implantable joint prostheses segment accounted for the largest share of the total rheumatoid arthritis market, whereas the spinal devices segment expected to witness double-digit growth rate in the coming years.
Market Analysis and Insights: Global and United States Rheumatoid Arthritis Devices Market
This report focuses on global and United States Rheumatoid Arthritis Devices market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Rheumatoid Arthritis Devices market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Implantable Joint Prostheses accounting for % of the Rheumatoid Arthritis Devices global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Elderly was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Rheumatoid Arthritis Devices market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global Rheumatoid Arthritis Devices Scope and Market Size
Rheumatoid Arthritis Devices market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Rheumatoid Arthritis Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Rheumatoid Arthritis Devices market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type, the Rheumatoid Arthritis Devices market is segmented into
Implantable Joint Prostheses
Spinal Devices
Other
Segment by Application, the Rheumatoid Arthritis Devices market is segmented into
Elderly
Young adults
Regional and Country-level Analysis
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Landscape and Rheumatoid Arthritis Devices Market Share Analysis
Rheumatoid Arthritis Devices market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Rheumatoid Arthritis Devices business, the date to enter into the Rheumatoid Arthritis Devices market, Rheumatoid Arthritis Devices product introduction, recent developments, etc.
The major vendors covered:
Active Implants LLC
Anika Therapeutics, Inc.
Arthrex, Inc.
Asahi Kasei Pharma Corporation
B. Braun Melsungen AG
CONMED Corporation
EMulate Therapeutics, Inc. (Nativis, Inc.)
Integra Lifesciences Corporation
Johnson & Johnson (DePuy Synthes Inc.)
Novartis AG
RTI Surgical, Inc.
Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.)
Setpoint Medical Corporation
Smith & Nephew plc (Osiris Therapeutics, Inc.)
Stryker Corporation (OrthoSpace Ltd.)
UCB Pharma S.A.
Zimmer Biomet


Table of Contents

    1 Study Coverage

    • 1.1 Rheumatoid Arthritis Devices Product Introduction
    • 1.2 Global Rheumatoid Arthritis Devices Outlook 2017 VS 2022 VS 2028
      • 1.2.1 Global Rheumatoid Arthritis Devices Sales in US$ Million for the Year 2017-2028
      • 1.2.2 Global Rheumatoid Arthritis Devices Sales in Volume for the Year 2017-2028
    • 1.3 United States Rheumatoid Arthritis Devices Outlook 2017 VS 2022 VS 2028
      • 1.3.1 United States Rheumatoid Arthritis Devices Sales in US$ Million for the Year 2017-2028
      • 1.3.2 United States Rheumatoid Arthritis Devices Sales in Volume for the Year 2017-2028
    • 1.4 Rheumatoid Arthritis Devices Market Size, United States VS Global, 2017 VS 2022 VS 2028
      • 1.4.1 The Market Share of United States Rheumatoid Arthritis Devices in Global, 2017 VS 2022 VS 2028
      • 1.4.2 The Growth Rate of Rheumatoid Arthritis Devices Market Size, United States VS Global, 2017 VS 2022 VS 2028
    • 1.5 Rheumatoid Arthritis Devices Market Dynamics
      • 1.5.1 Rheumatoid Arthritis Devices Industry Trends
      • 1.5.2 Rheumatoid Arthritis Devices Market Drivers
      • 1.5.3 Rheumatoid Arthritis Devices Market Challenges
      • 1.5.4 Rheumatoid Arthritis Devices Market Restraints
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Market by Type

    • 2.1 Rheumatoid Arthritis Devices Market Segment by Type
      • 2.1.1 Implantable Joint Prostheses
      • 2.1.2 Spinal Devices
      • 2.1.3 Other
    • 2.2 Global Rheumatoid Arthritis Devices Market Size by Type
      • 2.2.1 Global Rheumatoid Arthritis Devices Sales in Value, by Type (2017, 2022 & 2028)
      • 2.2.2 Global Rheumatoid Arthritis Devices Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.2.3 Global Rheumatoid Arthritis Devices Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    • 2.3 United States Rheumatoid Arthritis Devices Market Size by Type
      • 2.3.1 United States Rheumatoid Arthritis Devices Sales in Value, by Type (2017, 2022 & 2028)
      • 2.3.2 United States Rheumatoid Arthritis Devices Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.3.3 United States Rheumatoid Arthritis Devices Average Selling Price (ASP) by Type (2017, 2022 & 2028)

    3 Market by Application

    • 3.1 Rheumatoid Arthritis Devices Market Segment by Application
      • 3.1.1 Elderly
      • 3.1.2 Young adults
    • 3.2 Global Rheumatoid Arthritis Devices Market Size by Application
      • 3.2.1 Global Rheumatoid Arthritis Devices Sales in Value, by Application (2017, 2022 & 2028)
      • 3.2.2 Global Rheumatoid Arthritis Devices Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 Global Rheumatoid Arthritis Devices Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    • 3.3 United States Rheumatoid Arthritis Devices Market Size by Application
      • 3.3.1 United States Rheumatoid Arthritis Devices Sales in Value, by Application (2017, 2022 & 2028)
      • 3.3.2 United States Rheumatoid Arthritis Devices Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 United States Rheumatoid Arthritis Devices Average Selling Price (ASP) by Application (2017, 2022 & 2028)

    4 Global Rheumatoid Arthritis Devices Competitor Landscape by Company

    • 4.1 Global Rheumatoid Arthritis Devices Market Size by Company
      • 4.1.1 Top Global Rheumatoid Arthritis Devices Manufacturers Ranked by Revenue (2021)
      • 4.1.2 Global Rheumatoid Arthritis Devices Revenue by Manufacturer (2017-2022)
      • 4.1.3 Global Rheumatoid Arthritis Devices Sales by Manufacturer (2017-2022)
      • 4.1.4 Global Rheumatoid Arthritis Devices Price by Manufacturer (2017-2022)
    • 4.2 Global Rheumatoid Arthritis Devices Concentration Ratio (CR)
      • 4.2.1 Rheumatoid Arthritis Devices Market Concentration Ratio (CR) (2017-2022)
      • 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Rheumatoid Arthritis Devices in 2021
      • 4.2.3 Global Rheumatoid Arthritis Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.3 Global Rheumatoid Arthritis Devices Manufacturing Base Distribution, Product Type
      • 4.3.1 Global Rheumatoid Arthritis Devices Manufacturers, Headquarters and Distribution of Producing Region
      • 4.3.2 Manufacturers Rheumatoid Arthritis Devices Product Type
      • 4.3.3 Date of International Manufacturers Enter into Rheumatoid Arthritis Devices Market
    • 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 4.5 United States Rheumatoid Arthritis Devices Market Size by Company
      • 4.5.1 Top Rheumatoid Arthritis Devices Players in United States, Ranked by Revenue (2021)
      • 4.5.2 United States Rheumatoid Arthritis Devices Revenue by Players (2020, 2021 & 2022)
      • 4.5.3 United States Rheumatoid Arthritis Devices Sales by Players (2020, 2021 & 2022)

    5 Global Rheumatoid Arthritis Devices Market Size by Region

    • 5.1 Global Rheumatoid Arthritis Devices Market Size by Region: 2017 VS 2022 VS 2028
    • 5.2 Global Rheumatoid Arthritis Devices Market Size in Volume by Region (2017-2028)
      • 5.2.1 Global Rheumatoid Arthritis Devices Sales in Volume by Region: 2017-2022
      • 5.2.2 Global Rheumatoid Arthritis Devices Sales in Volume Forecast by Region (2023-2028)
    • 5.3 Global Rheumatoid Arthritis Devices Market Size in Value by Region (2017-2028)
      • 5.3.1 Global Rheumatoid Arthritis Devices Sales in Value by Region: 2017-2022
      • 5.3.2 Global Rheumatoid Arthritis Devices Sales in Value by Region: 2023-2028

    6 Segment in Region Level & Country Level

    • 6.1 North America
      • 6.1.1 North America Rheumatoid Arthritis Devices Market Size YoY Growth 2017-2028
      • 6.1.2 North America Rheumatoid Arthritis Devices Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.1.3 United States
      • 6.1.4 Canada
    • 6.2 Asia-Pacific
      • 6.2.1 Asia-Pacific Rheumatoid Arthritis Devices Market Size YoY Growth 2017-2028
      • 6.2.2 Asia-Pacific Rheumatoid Arthritis Devices Market Facts & Figures by Region (2017, 2022 & 2028)
      • 6.2.3 China
      • 6.2.4 Japan
      • 6.2.5 South Korea
      • 6.2.6 India
      • 6.2.7 Australia
      • 6.2.8 China Taiwan
      • 6.2.9 Indonesia
      • 6.2.10 Thailand
      • 6.2.11 Malaysia
    • 6.3 Europe
      • 6.3.1 Europe Rheumatoid Arthritis Devices Market Size YoY Growth 2017-2028
      • 6.3.2 Europe Rheumatoid Arthritis Devices Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.3.3 Germany
      • 6.3.4 France
      • 6.3.5 U.K.
      • 6.3.6 Italy
      • 6.3.7 Russia
    • 6.4 Latin America
      • 6.4.1 Latin America Rheumatoid Arthritis Devices Market Size YoY Growth 2017-2028
      • 6.4.2 Latin America Rheumatoid Arthritis Devices Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.4.3 Mexico
      • 6.4.4 Brazil
      • 6.4.5 Argentina
    • 6.5 Middle East and Africa
      • 6.5.1 Middle East and Africa Rheumatoid Arthritis Devices Market Size YoY Growth 2017-2028
      • 6.5.2 Middle East and Africa Rheumatoid Arthritis Devices Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.5.3 Turkey
      • 6.5.4 Saudi Arabia
      • 6.5.5 UAE

    7 Company Profiles

    • 7.1 Active Implants LLC
      • 7.1.1 Active Implants LLC Corporation Information
      • 7.1.2 Active Implants LLC Description and Business Overview
      • 7.1.3 Active Implants LLC Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2017-2022)
      • 7.1.4 Active Implants LLC Rheumatoid Arthritis Devices Products Offered
      • 7.1.5 Active Implants LLC Recent Development
    • 7.2 Anika Therapeutics, Inc.
      • 7.2.1 Anika Therapeutics, Inc. Corporation Information
      • 7.2.2 Anika Therapeutics, Inc. Description and Business Overview
      • 7.2.3 Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2017-2022)
      • 7.2.4 Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Products Offered
      • 7.2.5 Anika Therapeutics, Inc. Recent Development
    • 7.3 Arthrex, Inc.
      • 7.3.1 Arthrex, Inc. Corporation Information
      • 7.3.2 Arthrex, Inc. Description and Business Overview
      • 7.3.3 Arthrex, Inc. Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2017-2022)
      • 7.3.4 Arthrex, Inc. Rheumatoid Arthritis Devices Products Offered
      • 7.3.5 Arthrex, Inc. Recent Development
    • 7.4 Asahi Kasei Pharma Corporation
      • 7.4.1 Asahi Kasei Pharma Corporation Corporation Information
      • 7.4.2 Asahi Kasei Pharma Corporation Description and Business Overview
      • 7.4.3 Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2017-2022)
      • 7.4.4 Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Products Offered
      • 7.4.5 Asahi Kasei Pharma Corporation Recent Development
    • 7.5 B. Braun Melsungen AG
      • 7.5.1 B. Braun Melsungen AG Corporation Information
      • 7.5.2 B. Braun Melsungen AG Description and Business Overview
      • 7.5.3 B. Braun Melsungen AG Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2017-2022)
      • 7.5.4 B. Braun Melsungen AG Rheumatoid Arthritis Devices Products Offered
      • 7.5.5 B. Braun Melsungen AG Recent Development
    • 7.6 CONMED Corporation
      • 7.6.1 CONMED Corporation Corporation Information
      • 7.6.2 CONMED Corporation Description and Business Overview
      • 7.6.3 CONMED Corporation Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2017-2022)
      • 7.6.4 CONMED Corporation Rheumatoid Arthritis Devices Products Offered
      • 7.6.5 CONMED Corporation Recent Development
    • 7.7 EMulate Therapeutics, Inc. (Nativis, Inc.)
      • 7.7.1 EMulate Therapeutics, Inc. (Nativis, Inc.) Corporation Information
      • 7.7.2 EMulate Therapeutics, Inc. (Nativis, Inc.) Description and Business Overview
      • 7.7.3 EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2017-2022)
      • 7.7.4 EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Products Offered
      • 7.7.5 EMulate Therapeutics, Inc. (Nativis, Inc.) Recent Development
    • 7.8 Integra Lifesciences Corporation
      • 7.8.1 Integra Lifesciences Corporation Corporation Information
      • 7.8.2 Integra Lifesciences Corporation Description and Business Overview
      • 7.8.3 Integra Lifesciences Corporation Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2017-2022)
      • 7.8.4 Integra Lifesciences Corporation Rheumatoid Arthritis Devices Products Offered
      • 7.8.5 Integra Lifesciences Corporation Recent Development
    • 7.9 Johnson & Johnson (DePuy Synthes Inc.)
      • 7.9.1 Johnson & Johnson (DePuy Synthes Inc.) Corporation Information
      • 7.9.2 Johnson & Johnson (DePuy Synthes Inc.) Description and Business Overview
      • 7.9.3 Johnson & Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2017-2022)
      • 7.9.4 Johnson & Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Products Offered
      • 7.9.5 Johnson & Johnson (DePuy Synthes Inc.) Recent Development
    • 7.10 Novartis AG
      • 7.10.1 Novartis AG Corporation Information
      • 7.10.2 Novartis AG Description and Business Overview
      • 7.10.3 Novartis AG Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2017-2022)
      • 7.10.4 Novartis AG Rheumatoid Arthritis Devices Products Offered
      • 7.10.5 Novartis AG Recent Development
    • 7.11 RTI Surgical, Inc.
      • 7.11.1 RTI Surgical, Inc. Corporation Information
      • 7.11.2 RTI Surgical, Inc. Description and Business Overview
      • 7.11.3 RTI Surgical, Inc. Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2017-2022)
      • 7.11.4 RTI Surgical, Inc. Rheumatoid Arthritis Devices Products Offered
      • 7.11.5 RTI Surgical, Inc. Recent Development
    • 7.12 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.)
      • 7.12.1 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Corporation Information
      • 7.12.2 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Description and Business Overview
      • 7.12.3 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2017-2022)
      • 7.12.4 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Products Offered
      • 7.12.5 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Recent Development
    • 7.13 Setpoint Medical Corporation
      • 7.13.1 Setpoint Medical Corporation Corporation Information
      • 7.13.2 Setpoint Medical Corporation Description and Business Overview
      • 7.13.3 Setpoint Medical Corporation Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2017-2022)
      • 7.13.4 Setpoint Medical Corporation Products Offered
      • 7.13.5 Setpoint Medical Corporation Recent Development
    • 7.14 Smith & Nephew plc (Osiris Therapeutics, Inc.)
      • 7.14.1 Smith & Nephew plc (Osiris Therapeutics, Inc.) Corporation Information
      • 7.14.2 Smith & Nephew plc (Osiris Therapeutics, Inc.) Description and Business Overview
      • 7.14.3 Smith & Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2017-2022)
      • 7.14.4 Smith & Nephew plc (Osiris Therapeutics, Inc.) Products Offered
      • 7.14.5 Smith & Nephew plc (Osiris Therapeutics, Inc.) Recent Development
    • 7.15 Stryker Corporation (OrthoSpace Ltd.)
      • 7.15.1 Stryker Corporation (OrthoSpace Ltd.) Corporation Information
      • 7.15.2 Stryker Corporation (OrthoSpace Ltd.) Description and Business Overview
      • 7.15.3 Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2017-2022)
      • 7.15.4 Stryker Corporation (OrthoSpace Ltd.) Products Offered
      • 7.15.5 Stryker Corporation (OrthoSpace Ltd.) Recent Development
    • 7.16 UCB Pharma S.A.
      • 7.16.1 UCB Pharma S.A. Corporation Information
      • 7.16.2 UCB Pharma S.A. Description and Business Overview
      • 7.16.3 UCB Pharma S.A. Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2017-2022)
      • 7.16.4 UCB Pharma S.A. Products Offered
      • 7.16.5 UCB Pharma S.A. Recent Development
    • 7.17 Zimmer Biomet
      • 7.17.1 Zimmer Biomet Corporation Information
      • 7.17.2 Zimmer Biomet Description and Business Overview
      • 7.17.3 Zimmer Biomet Rheumatoid Arthritis Devices Sales, Revenue and Gross Margin (2017-2022)
      • 7.17.4 Zimmer Biomet Products Offered
      • 7.17.5 Zimmer Biomet Recent Development

    8 Industry Chain and Sales Channels Analysis

    • 8.1 Rheumatoid Arthritis Devices Industry Chain Analysis
    • 8.2 Rheumatoid Arthritis Devices Key Raw Materials
      • 8.2.1 Key Raw Materials
      • 8.2.2 Rheumatoid Arthritis Devices Distributors
    • 8.3 Rheumatoid Arthritis Devices Production Mode & Process
    • 8.4 Rheumatoid Arthritis Devices Sales and Marketing
      • 8.4.1 Rheumatoid Arthritis Devices Sales Channels
      • 8.4.2 Rheumatoid Arthritis Devices Distributors
    • 8.5 Rheumatoid Arthritis Devices Customers

    9 Research Findings and Conclusion

      10 Appendix

      • 10.1 Research Methodology
        • 10.1.1 Methodology/Research Approach
        • 10.1.2 Data Source
      • 10.2 Author Details

      Summary:
      Get latest Market Research Reports on Rheumatoid Arthritis Devices. Industry analysis & Market Report on Rheumatoid Arthritis Devices is a syndicated market report, published as Global and United States Rheumatoid Arthritis Devices Market Report & Forecast 2022-2028. It is complete Research Study and Industry Analysis of Rheumatoid Arthritis Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,850.00
      		$7,700.00
      		2,976.05
      		5,952.10
      		3,584.35
      		7,168.70
      		587,856.50
      		1,175,713.00
      		324,940.00
      		649,880.00
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo